Health
COVID-19 vaccine developed by German research group fails in early trial – TheChronicleHerald.ca
FRANKFURT (Reuters) – A coronavirus vaccine developed by the German Centre for Infection Research (DZIF) and vaccine maker IDT Biologika did not prompt the hoped-for…
FRANKFURT (Reuters) – A coronavirus vaccine developed by the German Centre for Infection Research (DZIF) and vaccine maker IDT Biologika did not prompt the hoped-for immune reaction in early-stage testing on humans, trial organisers at university hospital Hamburg-Eppendorf (UKE) said on Friday.
Further testing has been suspended until the cause for the weak immunogenicity in the Hamburg trial involving 30 volunteers has been established, UKE said in a statement, adding that the vaccine was well…
-
Noosa News23 hours agoWest Coast Eagles draftee Josh Lindsay wants to carry on Troy Selwood’s legacy
-
Noosa News24 hours agoHunt for suspects after family’s pregnant horse found shot dead on rural Queensland property
-
General10 hours agoGrieving parents of 4yo boy who drowned in Officer suing Melbourne Water, Cardinia council
-
Noosa News19 hours agoYummy Snack Foods pulled from shelves over labelling issue